Could ETQ's share price be soon to benefit from their developments with the new UVGI Nightingale Mobile Air Filtration Product.

New UVGI air filtration product

In November 2002, the ETQ announced its new Nightingale UVGI air filtration product, to be produced by a new joint-venture company, UVGI Systems Limited, owned 55% by the Group and 45% by Suvair Limited. This rapid response mobile air filtration unit is capable of killing the MRSA super bug and other airborne pathogens.

The UVGI unit has widespread application where there is need to keep
air free of dangerous live bacteria, viruses, and fungal spores, including
hospitals, schools, cruise liners, aircraft, food processing, and military
applications.

The UVGI unit uses a high intensity Ultra Violet Germicidal Irradiation ('UVGI')
filter, which has been designed to control harmful and dangerous airborne
pathogens, such as Anthrax, Tuberculosis, and Staphylococcus aureus, the
causative agent in MRSA. The filtration system is combined with use of high
intensity Ultra Violet light, which inactivates micro organisms by disrupting
their DNA structure.

Tests of a prototype at the Defence Science Technology Laboratory ('Dstl') at
Porton Down, the centre for excellence for the Ministry of Defence, showed that
the UVGI unit captured and/or destroyed more than 99.9% of Bacillus subtilis
spores, a simulant for Anthrax bacteria.

Since November, second generation units have been developed, which will go on
applications testing at an NHS Trust Hospital in December 2003, following
building completion of its new haematology unit. It is also anticipated the
UVGI unit will shortly go on laboratory testing in the United States with
contractors nominated by the Department of Homeland Security.

Concern seems to be hotting up on the T.V. news that the MRSA super bug is still killing and disabling people visiting or as patients in NH Trust hospitals. It would be surprising if NH Trust hospital do not notice and Buy this product before they get to many expensive law suits for compensation claims.

Definitely a stock that could soon be heading north. Worth buying in but DYOR

L.

RELATED NEWS LINKS

Sky News Sun 28th Sept 03 - NEW ANTIBIOTICS WARNING
BBC World News Thurs 4th December 03 - Hospital infections: Case studies
BBC World News Fri 5th Dec 03 - 'Superbug' crackdown is launched
BBC World News Monday 22nd Dec 03 - Superbugs lurk in intensive care
Sky News Sun 14th Dec 03 - SUPERBUG CARRIED BY PETS
BBC World News Thurs 26th Feb 04 - Superbug deaths increase 15-fold
BBC World News Mon 22nd March 04 - MRSA superbug hits more children
BBC World News Fri 2nd April 04 - Superbug outbreak in cardiac ward
BBC World News Thurs 8th April 04 - NHS faces superbug legal claims
BBC World News Sun 6th June 04 - Government 'complacent' over MRSA
BBC World News Fri 18th June 04 - Superbug deaths 'set to double'
BBC World News Thurs 1st July 04 - Holland's tough line combats MRSA
BBC World News Thurs 1st July 04 - Overcrowded hospitals breed MRSA
ITV.com Fri 9th July 04 - Mother's MRSA nightmare
ITV.com Fri 9th July 04 - 'MRSA superbug has done this to me'
ITV.com Fri 9th July 04 - Precautions you can take against MRSA
Sky News Sun 11th July 04 - WAR DECLARED ON MRSA
BBC UK News Mon 12th July 04 - Drive to fight hospital superbugs

Hi suehelen had to pay 5.5p today. Thankx some good post today on III today.
Looks like when resistance at 5.5p is overcome we could have some good upside to test the previous high. Not tempted into CMS at the moment ?, im very bearish (chart looking dead )possible further downgrading of contracts that were expected to be signed.

Hi momentum, that was still a good price.

We finished with a shooting star (see below candlesticks chart) on the candlesticks for today which is a bullish signal. Buyers came back today and the selling appears to finish as re: my post yesterday but today the buys outnumbered the sells (see trades page). Price finishing up 4.90% today to 5.00-5.75 though the real spread seemed to be about 5.10-5.50 pence. Level 2 closing at 3 v 1 which is the strongest it can get for the second day running. I expect another blue day tomorrow.



Stars make up part of four separate reversal patterns:

Morning Star

Evening Star

Doji Star

Shooting Star (Inverted Hammer)

Shooting Star -- a small real body near the lower end of the trading range, with a long upper shadow. The color of the body is not critical. Not usually considered a major reversal sign, only a warning.

http://www.tradersedgeindia.com/candlestick.htm

Memo from Graham Mackenzie below : reply to an email sent.

Thank you for your e mail comments.

I would respond to your comments as follows.

The ETQ share price has fallen back slightly in the past few days because there has been heavy selling of shares because of profit taking by certain investors who took up stock in the recent placing, and because one major shareholder from the original consortium that bought in to ETQ three years ago, Harrel Hospitality has sold its complete holding in the company in order we believe to finance a hotel purchase.That sales have resulted in great liquidity in the stock.

As regards the marketing of Nightingale you should not forget that this is a sophisticated product selling for 6000 to 8500 pounds depending on the spec.. This is not a consumer sale so our marketing is directed at NHS Trusts and the private hospital groups such as BUPA. Any consumer or media coverage is peripheral to the main marketing effort where, for example, ETQ has made presentations to two major NHS Infection Control conferences in the last few weeks.

You can be assured that every hospital Chief exec and infection control director in the NHS has been made aware of Nightingale.

The problem is the bureaucratic morass of NHS purchasing procedures which delay the procurement process endlessly.

Why don't you tackle your local MP about the general comments you make about infection control in the NHS? We stand willing to supply Nightingale and have ensured that we have several in stock for immediate delivery should a hospital break out of its red tape and order one.

Regards
Graham Mackenzie

This is a link to one of the presentations he mentioned.

http://www.otjonline.com/download/june04.pdf (page 14)

and also this:

http://www.otjonline.com/download/may04.pdf (page 12)

On 28 April 2004, Joseph Tufo, Managing Director of UVGI Systems
Ltd. gave a presentation to 160 delegates at the Tackling Infection
Control conference held at the Copthorne Tara Hotel in London.
Participating in the conference was leading infection control
specialists, consultant microbiologists and clinical governance
managers from across the UK.
Mr. Tufo presented on the importance of air quality in the built
environment and explained how technology has advanced from simple
HEPA fi lters to products such as UVGIs Nightingale unit which draws
in air and includes four primary levels of protection including HEPA
fi lters plus a decontaminating section containing two banks of four
low-pressure UV lamps, located outside the airstream behind quartz
screens. Mr. Tufo described the problems associated with airborne
microbials and how UV treatment can sanitise bacteria.
Kathy Lee, an Acute Medical Ward Sister with over 30 years experience
in the NHS, then discussed treatment of immuno-compromised and
infectious patients, including a case study at North Hampshire hospital,
Basingstoke on using Nightingale to create a positive pressure room
and similar experience in handling SARS at a Toronto Hospital with
negative pressurisation. In these studies, another advantage of the
Nightingale system was the added benefi t of being highly mobile.
Other presentations at the conference included Nigel Tomlinson,
Principal Scientifi c Advisor, Centre for Healthcare Engineering, NHS
Estates who stated that early tests by NHS Estates had indicated the
positive results shown by UV treatment of airborne antimicrobials and
the likely recommendation from NHS Estates as to the use of such UV
fi ltering systems in hospitals.
Different forms of tackling control were also described at the
conference including a presentation from Julie Storr, Assistant Director
of Safety Solutions, NPSA who talked about the NHS clean your
hands campaign to encourage patients to ask nursing and medical
staff if they has cleansed their hands prior to treatment.
Other topics discussed included understanding the impact of the NHS
Winning Ways directive. Dr Louise Teare, Director of Infection Control
and Consultant Microbiologist at Mid-Essex Hospital Services NHS
Trust described interpreting the infection control timetable and what is
required including integrating infection control with clinical governance
and care planning.
The fi rst multi-parameter test - Cardiac Risk
- tests for total cholesterol, HDL, LDL and
triglycerides. The Cardiac Risk test identifi es
and monitors patients at risk of developing
Coronary Heart Disease (CHD), the leading
cause of death in North America and Europe.
Additional strips under development include
tests for renal, liver and metabolic functions.
For further information please contact:
Will Col, Oxford Biosensors Ltd,
Oxford Industrial Park, Mead Road,
Yarnton, Oxfordshire OX5 1QU.
Tel: 01865 849100. Fax: 01865 849200.
email: will.collon@Oxford-Biosensors.com
Website: www.Oxford-Biosensors.com
When responding to adverts please quote OTJ
The presenters informed the audience about the methods for tackling
infection and how to comply with current NHS legislation and guidelines.
The Chief Medical Offi cers publication of Winning Ways in December
2003 put the onus for effective infection control fi rmly onto the senior
management of acute trusts. Without improved infection control,
hospitals star ratings will be affected, the patient experience will be
compromised, billions of pounds may be squandered and thousands of
lives could be lost.
The strong line-up of speakers helped to address issues of infection
control, clinical governance and the Winning Ways directive as well as
tackling crucial questions of accountability, risk management and how to
carry out increased surveillance and reporting requirements, as well as
those of staffi ng and resourcing change.
For further information please contact:
Joseph Tufo, UVGI Ltd
Telephone: 01256 814162 joe@uvgi.co.uk
Joseph Tufo and Kathy Lee present at the Tackling Infection Control
meeting in London.
Tackling infection control is the priority for UVGI

UVGI Ltd. have jointly sponsored a meeting entitled Redesigning
Chronic Disease Management which was held on 25th May at the
Sheraton Park Lane Hotel, London. The one-day conference included a
keynote lecture from Sir Liam Donaldson, Chief Medical Offi cer.
The subject of chronic disease management is of major signifi cance to
UVGI who manufacture Nightingale, a new environmental disinfection
method that uses ultraviolet light to tackle the problem of hospitalbased
pathogens. The Nightingale is the fi rst ever British mobile air
sanitisation system with the ability to provide positive or negative
room pressurisation in line with CDC and NHS guidelines.
The UVGI sponsored meeting was specifi cally designed for Primary
Care Trusts. The conference addressed the overall issue of the
management of Chronic Medical conditions, specifi cally concentrating
on the practicalities of implementing a coordinated approach.
With the introduction of new initiatives, including the Expert Patient
Programme, hospitals now recognise the opportunity to make a
signifi cant change to the care and management of chronic disease.
Some of the crucial issues that were covered included how to learn
lessons from the US on case management of chronic disease, training
and development of staff to avoid unnecessary hospital admissions
and taking a whole systems approach to redesigning chronic disease
management.
Chronic diseases can affect as many as 17.5 million adults in the
UK and represent a huge and increasing burden on NHS resources.
International experience has shown that better integration between
primary, secondary and social care can reduce hospitalisation and yet
provide better care for patients. PCTs are in the ideal position to bridge
the gap and plan for integrated care. In order to meet this challenge
services will need to be replanned and redesigned to give a more
coordinated, responsive and integrated approach.
Speakers, including Sir Liam Donaldson, Chief Medical Offi cer and
Gary Belfi eld, Head of Primary Care and Policy for Chronic Disease,
Department of Health, discussed experiences including patient selfmanagement
programmes, the development of staff skills, multi-agency
integrated working and preventative measures to avoid unnecessary
and inappropriate hospital admissions. The authoritative panel of
speakers described the different models of care available, giving the
audience the opportunity to update on the latest trends taking place
nationwide and receive advice on how to take forward current systems
and procedures.
A panel discussion and Q&A sessions gave an excellent opportunity
to question experts and share views. The audience numbered 260
with delegates working in Nursing, Operations, Intermediate Care,
Commissioning, Clinical Leads as well as those involved in the
planning, commissioning and delivery of chronic disease management
services.
For further information please contact: Joseph Tufo UVGI Ltd
Telephone: 01256 814162 E-mail: joe@uvgi.co.uk
UVGI sponsor

Further : They mention UVGI rather than ETQ in the above but it is ETQ's presentation promoting UVGI.

In the second one there was a reference to an NHS Estates chap who really liked it and was going to recommend to the Trusts that they take up UV.

Some good news out today :

Evolution Beeson Gregory (Evo) have upgraded Energy Technique (ETQ) from Overweight to BUY!! It was on Bloomberg.

That explains why EVO moved from the offer to the bid on Level 2 and were actively bidding for stock.

Evolution Beeson Gregory Website :

Don't think we can get in though as if one selects private individual then the registration doesn't seem to complete.

http://www.evbgresearch.com/

The last candle in post 122 in in fact a doji and a bearish doji at that


macd is definitely not positive. Anyone thinking of buying should wait to see if there is a bounce off 4p with strong positive volume

EVO just bought out a new buy note.

The 500,000 trade reported at 5.25 pence this morning which has appeared in the sell column is a buy. The buy was filled when the offer price dropped to 5.50 pence for a few seconds before going back up to 5.75 pence. That action happened roughly before the buy went through at 09.27 and reported 1 hour later.
WINS also changed to the bid at 9:27.
The 500K was a definite buy and the buys outweigh the sells, I saw we've the movement on L2 just before the buy was put through at 09.27, the movement of the MM's. The price was 5.00-5.50 pence when the 500K order was put through. Then the offer ticked back up to 5.75 pence.
The other 500K trade at 5.00 pence on Tuesday was also a buy.
Someone has been hovering up all the sells this week, sells have been very small in size since last week and the buys that have come fewer but have been large.

Technical Analysis from Yahoo Finance updated today :

Technical Analysis: Energy Technique (ETQ.L) Last Time Updated Thursday July 29

Short Term Commentary

Watch out for price pullbacks, since levels under 7.43 can be opportunities to enter long in the market, when the trend slope at its highest levels.

Medium Term Commentary

Medium term price trend for Energy Technique is still bullish this week. This stock underperforms the FTSE 100 INDEX by -29.97 %. Volatility has been increasing during last month.

http://uk.biz.yahoo.com/tech/e/etq.l.html

We have another bullish candlestick on the charts for today : same as the one that appeared before the news came and the big rise happened (see below candlesticks chart). In addition, interestingly, the candlestick on the charts we have for today is the same one CFP had yesterday and CFP is up 23.00% today.

Bearish last candle on this chart says much more than an indecision doji on the above chart. Note the fact that higher prices were attempted but did not hold plus the downward pointing MA

** it is dangerous to trade against the trend. This is a falling knife scenario **



PS I no longer hold shares in this stock so am unpredjudiced

if you must buy then wait for good positive buying volume on your own chart. My chart shows that OBV (on balance volume) is falling

Best - Charts :

On Balance Volume is Bullish.

definitely not. Updata TA realtime chart. Daily

Potential punters: look at charts on different time scales. If you want to buy and hold then look at a longer-term chart wrt the primary trend

IMO this stock will (and should) test 4p. If it bounces off 4p with good volume then even I would buy it

I've just checked with Best-Charts. Volume Balance is also positive, confirmed by Investtech.
With regards to the trades, the small sells less than 50K appearing don't interest me, the 500K buys is what I am interested in. We will know the reason for the 500K block buys soon.

Investtech Analysis after today's close :

Weak Positive Candidate (Short term) - Jul 29, 2004
Has broken the ceiling of the falling trend, which indicates a slower initial falling rate. The stock has support at p 5.00 and resistance at p 6.00. Volume tops and volume bottoms correspond well with tops and bottoms in the price. This strengthens the stock. The stock is overall assessed as technically slightly positive for the short term.

Weak Positive Candidate (Long term) - Jul 29, 2004
Shows a weak development within a falling trend channel. A further negative development is indicated, and there is resistance against the ceiling of the trend channel. Has reacted back after the break of the inverse head and shoulders formation. There is support around 3.79, which now indicates good buying opportunities. An established break through this support will neutralize the positive signal. The stock has support at p 2.70 and resistance at p 11.20. Volume tops correspond well with price tops, and volume bottoms correspond well with price bottoms. Volume balance is also positive, which weakens the falling trend and could be an early signal for a coming trend break. Trading volume has increased substantially lately. This shows there is an increased interest for the stock, possibly because of fundamental news. The stock is overall assessed as technically slightly positive for the long term.